Related Experiment Video
Updated: May 6, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
[Endothelial microparticles and erectile dysfunction: an update]
Yong-Xian Li1, Rui Jiang, Guo-Sheng Yang
1Department of Urology, The Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan 646000, China. 168794871@qq.com
Abstract:
Microparticles are submicron vesicles shed from plasma membranes in response to cell activation, injury and/or apoptosis. Microparticles of various cellular origins, such as platelets, leukocytes, and endothelial cells, are found in the plasma of healthy subjects, and their amount increases under pathological conditions. Recent studies show that endothelial microparticles, a kind of envelope particles derived from endothelial cells, not only constitute a marker of endothelial dysfunction, but also play a major biological role in the diagnostic and therapeutic approaches to erectile dysfunction.
Insights
Microparticles are tiny vesicles from cell membranes. Endothelial microparticles, from cells lining blood vessels, are key markers for endothelial dysfunction and play a role in diagnosing and treating erectile dysfunction.
Area of Science:
- Biochemistry
- Cell Biology
- Vascular Biology
Context:
- Microparticles are vesicles released from cell membranes during activation, injury, or apoptosis.
- Elevated levels of microparticles are observed in various pathological conditions.
- Endothelial microparticles (EMPs) originate from endothelial cells, which line blood vessels.
Purpose:
- To explore the role of endothelial microparticles in endothelial dysfunction.
- To investigate the diagnostic and therapeutic potential of EMPs in erectile dysfunction (ED).
Summary:
- EMPs are shed from activated or damaged endothelial cells.
- Increased EMP levels are associated with endothelial dysfunction.
- EMPs are implicated in the pathophysiology of erectile dysfunction.
Impact:
- Endothelial microparticles serve as significant biomarkers for endothelial dysfunction.
- EMPs offer potential diagnostic and therapeutic strategies for managing erectile dysfunction.
- Understanding EMPs contributes to advancing cardiovascular and urological research.
More Related Videos
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

